Description

Cyclopropanecarboxamide, n-(2,3-Dihydroimidazo[1,2-C]Quinazolin-5-Yl)- (9Ci) is a high-purity, specialized organic compound featuring a fused quinazoline-imidazole core structure. This molecule is of significant interest in advanced pharmaceutical research and development, particularly as a key synthetic intermediate or a potential pharmacophore for novel active pharmaceutical ingredients (APIs). It is primarily sought by research institutions and pharmaceutical companies engaged in the discovery of new therapeutic agents. The compound's unique heterocyclic architecture makes it a valuable building block for medicinal chemistry programs targeting a range of biological pathways.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of novel drug candidates, especially in oncology and central nervous system (CNS) therapeutic areas.
• Medicinal Chemistry Research: Used as a core scaffold or building block for structure-activity relationship (SAR) studies to optimize potency and selectivity of lead compounds.
• Biochemical Tool Compound: Employed in vitro and in vivo to probe specific biological targets and validate novel mechanisms of action in early-stage drug discovery.
• Reference Standard: Provides a high-purity analytical standard for quality control and method development in API manufacturing and regulatory submissions.
• Contract Research & Development (CRO/CMO): Supplied to outsourcing partners for custom synthesis and process development projects.

Basic Information

Product Name	Cyclopropanecarboxamide, n-(2,3-Dihydroimidazo[1,2-C]Quinazolin-5-Yl)- (9Ci)
CAS No.	677341-05-8
Molecular Formula	C₁₄H₁₂N₄O
Molecular Weight	252.27 g/mol
Synonyms	N-(2,3-Dihydroimidazo[1,2-c]quinazolin-5-yl)cyclopropanecarboxamide; 5-(Cyclopropanecarboxamido)-2,3-dihydroimidazo[1,2-c]quinazoline; Cyclopropanecarboxamide, N-(2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-; UNII-8V9J8F8F8R; 8V9J8F8F8R; CAS 677341-05-8
EINECS	Contact for details

Quality Control

Our Cyclopropanecarboxamide, n-(2,3-Dihydroimidazo[1,2-C]Quinazolin-5-Yl)- (9Ci) is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and spectroscopic identification (NMR, MS), to ensure it meets the exacting standards required for research and development. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting batch-specific results.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The compound is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.